Kidney Cancer
Prostate Cancer
EAU Edu Platform on Bladder Cancer
Home
Articles
Article of the Month
Editorial
Videos
Webcasts
Education
E-courses
Webinars
ESOU Online
Clinical problems
Guidelines
Events
Home
Articles
Terug
Article of the Month
Editorial
Videos
Webcasts
Education
Terug
E-courses
Webinars
ESOU Online
Clinical problems
Guidelines
Events
Upcoming event
Masterclass on Non-muscle-invasive bladder cancer
Home
/
EAU21
Back
Tag:
EAU21
EAU21: Virtual meeting but crucial findings!
View
DANUBE post-hoc analysis: Outcomes for durvalumab with or without tremelimumab by cisplatin eligibility and PD-L1 biomarker status in metastatic urothelial carcinoma
View
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
View
PURE-02: An open-label, single-arm, feasibility study of neoadjuvant pembrolizumab before Radical Nephroureterectomy (RNU) in patients with high-risk, Upper-Tract Urothelial Carcinoma (UTUC)
View
Safety evaluation of sequential Mitomycin and Bacillus Calmette-Guérin treatment versus Bacillus Calmette-Guérin monotherapy in patients with high risk non-muscle invasive bladder cancer: MITOBCG study (EUDRACT Number 2017-004540-37) preliminary results
View
A randomized clinical trial of intravesical instillation of MMC and combination of MMC and Ara-C in non-muscle invasive bladder cancer
View
The effect of a neoadjuvant instillation of chemotherapy in the prevention of recurrences of non-muscle invasive bladder cancer. Preliminary results of the PRECAVE prospective, controlled, randomized clinical trial
View
Subgroup analyses of the phase 3 study of intravesical nadofaragene firadenovec in patients with high-grade, BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)
View
Upper Tract TCC
View
Active surveillance is the best choice, patients can enjoy life before treatment!
View
